Skip to Content
Søg Menu
Mats Jerkeman

Several Options for Frontline Treatment of MCL

/ Mats Jerkeman
EHA25Lymfom Play the Video
Paolo Ghia

EHA 2025: Durable Undetectable MRD Responses with Acalabrutinib in CLL

/ Paolo Ghia
EHA25CLL Play the Video
Mats Jerkeman

EHA 2025: Signs of Functional Cure for MCL in 25 Years Nordic Follow-Up Study

/ Mats Jerkeman
EHA25Lymfom Play the Video
Chan Cheah

EHA 2025: Sonrotoclax + Zanubrutinib Show Durable Responses in R/R CLL/SLL

/ Chan Cheah
EHA25CLL Play the Video
Paolo Ghia

EHA 2025: Zanubrutinib Effective as First-Line CLL/SLL Therapy Regardless of del(17p)

/ Paolo Ghia
EHA25CLL Play the Video
Hanne Norseth

EHA 2025: TG01 Shows Promise in KRAS-Mutated Myeloma

/ Hanne Norseth
EHA25Myelomatose Play the Video

The 2025 EHA Award Recipients

/ Amanda Feldballe Bernholm
EHA25
Anne Louise Tølbøll Sørensen

EHA 2025: Nordic AML Group Explores Optimized Regimen for AML Patients

/ Anne Louise Tølbøll Sørensen
EHA25AML Play the Video
Frida Bugge Askeland

EHA 2025: Impact of Treating MRD Relapse Post 1L in Multiple Myeloma

/ Frida Bugge Askeland
EHA25Myelomatose Play the Video
Tahreem Ghazal Siddiqui

Dose Reduction or Stopping Inappropriate Z-Hypnotic Use in Older Adults

/ Tahreem Ghazal Siddiqui
EAN24Søvnproblemer Play the Video
Tahreem Ghazal Siddiqui

Older Adults in Primary Care Have a High Prevalence of Self-Reported Sleeping Problems

/ Tahreem Ghazal Siddiqui
EAN24Søvnproblemer Play the Video

Psychological and Behavioral Symptoms in Patients with Melanoma

/ Josefine Tingdal Taube Danielsen / Louise Strøm / Sofie Møgelberg Knutzen / Henrik Schmidt / Ali Amidi / Lisa M. Wu / Robert Bobby Zachariae
HudcancerSøvnproblemerLivskvalitetDepressionAngst
Hent flere
Back to top